GeneReach Biotechnology Corp. (TPEX: 4171)
Health Care · Health Care Equipment & Supplies · TW
NT$17.25
+1.17% today · -13.3% 1Y
GeneReach Biotechnology Corp. (TPEX: 4171) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $31.04M and employs 120 people.
Over the last twelve months the share price has lost 13.3%, trading between 16.35 and 26.90.
Tweenvest scores GeneReach Biotechnology Corp. across four factors: quality 50/100, value 75/100. Its strongest factor is value.
4171 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $31.04M
- Revenue (TTM)
- $7.48M
- P/E
- —
- EPS
- -0.75
- Dividend yield
- —
- Beta (5Y)
- 0.38
- 52-week high
- NT$26.90
- 52-week low
- NT$16.35
- Avg volume (3M)
- —
- Shares outstanding
- 57.30M
- Employees
- 120
- Next earnings
- —
About GeneReach Biotechnology Corp.
GeneReach Biotechnology Corp., a company based in Taichung, Taiwan, specializes in the development, production, and commercialization of advanced nucleic acid detection technologies. The company's extensive product line features essential laboratory instrumentation, including automated nucleic acid extraction systems, prep homogenization systems, and mini centrifuges. GeneReach also provides a wide range of reagents and consumables, such as human In Vitro Diagnostic (IVD) assays, specific iiPCR reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and various research-grade reagents and supplies. Beyond its product offerings, GeneReach delivers comprehensive services. These encompass polymerase chain reaction (PCR) training programs, expert molecular diagnostic technical solutions, laboratory installation assistance, OEM/ODM contract manufacturing capabilities, and collaborative research services. Its innovative solutions cater to a diverse clientele, with applications spanning aquaculture, agriculture, food safety, human health, and the welfare of companion animals and livestock. GeneReach Biotechnology Corp. was established in 2004.
- ISIN
- TW0004171004
- Founded
- 2004
- Listed since
- Nov 19, 2012
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.84 | -0.46% |
| Stryker CorporationNYSE: SYK | $126.81B | $330.59 | +0.85% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $49.86 | +1.73% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.